| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 195,081 | 176,143 | 187,367 | 255,862 | | Cost of Revenue | 157,412 | 140,235 | 149,676 | 212,252 | | | Gross Profit | 37,669 | 35,908 | 37,691 | 43,610 | | | Operating Expenses | | Research Development | 38,883 |
-
|
-
|
-
| | Selling General and Administrative | (1,060) | 35,975 | 40,783 | 37,928 | | Non Recurring |
-
| (218) |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (154) | 151 | (3,092) | 5,682 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 308 | 981 | 1,859 | (3,842) | | Earnings Before Interest And Taxes | 154 | 1,132 | (1,233) | 1,840 | | Interest Expense | 941 | 743 | 866 | 826 | | Income Before Tax | (787) | 389 | (2,099) | 1,014 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (787) | 389 | (2,099) | 1,014 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (787) | 389 | (2,099) | 1,014 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($787) | $389 | ($2,099) | $1,014 |
|
0.51% Nasdaq 
0.15 (1.09%) 
Income Statement
